Appropriateness of the medication Tendency of developing a delirium Cognitive skills Agitation Mobility
Conditions
Interventions
Group 1: The Intervention InTherAKT comprises two components:
- Transprofessional expansion of knowledge by means of a three-part training program on drug therapy safety in elderly people for care sta
(2) The GP reviews the medication plan and shares it with the care staff
(3) The pharmacist carries out the type 1 medication analysis (Grundsatzpapier zur Medikationsanalyse [policy paper on medication analysis], ABDA, 2014)
(4) The GP makes ano
Sponsors
Grünenthal GmbH
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: Residents: Participation consent, age > 64 years, drug therapy. Professional groups: GPs, geriatric nurses with three years of training, occupational health nurses with three years of training, pharmacists, trained pharmaceutical technicians, trained medical assistants.
Exclusion criteria
Exclusion criteria: Residents: Missing declaration of consent of the resident, missing declaration of consent of the legal guardian, insufficient cognitive performance for making independent decisions and no legal guardian, age < 65 years, acute life-threatening situation, isolation due to acute infections or multiresistant germs. Professional groups: care workers with no three-year training in nursing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Quantitative part: Appropriateness of the recorded drug therapy of the residents at t0 (baseline, i.e. before the intervention), t1 (after 7 months) and t2 (after 13 months), measured by means of the Medication Appropriateness Index (MAI) (Hanlon, 1992). - Qualitative part: Changes in interprofessional communication and cooperation between the participating professional groups, qualitatively collected by means of group interviews at t0 and t2. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Cognitive abilities of the included residents, measured by means of the Mini-Mental State Examination (MMSE) (Folstein, 1975; Tombaugh, 1992; Kaiser, 2009) and the Dementia Screening Scale (DSS) (Köhler, 2007) at t0, t1 and t2 - Probability of the included residents of developing a delirium, measured by means of the Delirium Observation Screening Scale (DOS) (Schuurmans, 2003) at t0, t1 and t2 - Agitation in people with cognitive impairments (MMST < 18) (Rösler, 2003), measured by means of the Cohen Mansfield Agitation Inventory (CMAI-D) (Stoffel, 2010) at t0, t1 and t2 - Mobility and tendency of falling of the included residents, measured by means of the Timed Up and Go (TUG) Test (Podsiadlo, 1991) at t0, t1 and t2 - Total number of medicines prescribed for the study participants at t0, t1 and t2 - Number of potentially dangerous drug interactions, measured by means of the ABDA database at t0, t1 and t2 - Appropriateness of the recorded analgesics, measured by means of the Medication Appropriateness Index (MAI) at t0, t1 and t2 Start of data collection t0: 20 July – 30 September 2015 Data collection t1: after 7 months Data collection t2: after 13 months | — |
Countries
Germany
Contacts
Public ContactNadja Nestler
Paracelsus Medizinische PrivatuniversitätInstitut für Pflegewissenschaft und -praxis
Outcome results
None listed